Basics Mineralys Therapeutics, Inc. IPO Date: February 10, 2023 Sector: Healthcare Industry: Biotech Market Cap: $2.7B Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 2.94% Avg Daily Range (30 D): $0.78 | 4.26% Avg Daily Range (90 D): $0.50 | 3.06% Institutional Daily Volume Avg Daily Volume: .35M Avg Daily Volume (30 D): 1.58M Avg Daily Volume (90 D): .95M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 74 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 368 Avg Inst. Trade: $1.8M Avg Inst. Trade (30 D): $1.96M Avg Inst. Trade (90 D): $1.96M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.31M Avg Closing Trade (30 D): $2.4M Avg Closing Trade (90 D): $2.14M Avg Closing Volume: 151.7K     News Sep 7, 2025 @ 12:23 PM These 2 Healthcare Stocks More Than Doubled Recent... Source: Cory Renauer Sep 5, 2025 @ 1:00 PM Mineralys Therapeutics Presents Subgroup Analyses ... Source: Mineralys Therapeutics Sep 3, 2025 @ 1:33 AM Mineralys Therapeutics Announces Pricing of Upsize... Source: Mineralys Therapeutics May 24, 2025 @ 8:30 AM Mineralys Therapeutics Announces Late-Breaking Pre... Source: Mineralys Therapeutics Mar 29, 2025 @ 6:30 PM Mineralys Therapeutics Announces Late-Breaking Dat... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.66 $-.79 Diluted EPS $-.66 $-.79 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -43.27M $ -42.21M Operating Income / Loss $ $ -46.75M $ -44.45M Cost of Revenue $ $ $ Net Cash Flow $ $ -63.22M $ 50.92M PE Ratio